Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Baxalta now part of Shire
Age
13–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
13 to 65 years old at the time of screening
has moderately severe or severe hemophilia A or B (FVIII/FIX level
≤2%), with or without transient inhibitors
Hemophilia A patient currently prescribed ADVATE (FVIII) or Hemophilia B patient currently prescribed RIXUBIS (FIX)
previously treated with plasma-derived FVIII/FIX concentrates or recombinant FVIII/FIX for ≥150 documented exposure days (EDs)
is willing and able to comply with the requirements of the protocol
is proficient in the English language to allow for use of the SPACE eDiary
You may not be if
inhibitor titer ≥0.6 Bethesda units or currently being treated for an inhibitor
has participated in another clinical study involving a medicinal product or device within 30 days prior to enrollment or is scheduled to participate in another clinical study involving a medicinal product or device during the course of this study
is a family member or employee of the investigator
elective major surgery is planned within 6 months after enrollment which may interfere with activities of daily living (at investigator's discretion)
